Research into Bipolar i disorder spans multiple therapeutic approaches and trial phases.

12 total trials for this combination

Showing top 10 of 12 trials

Trials

NCT ID	Title	Status	Phase
NCT05658510	Dexmedetomidine in the Treatment of Agitation Associated With Schizophrenia and Bipolar Disorder (SERENITY III)	COMPLETED	PHASE3
NCT00227305	Quetiapine Fumarate (SEROQUEL) in the Treatment of Adolescent Patients With Schizophrenia and Bipolar I Disorder	COMPLETED	PHASE3
NCT05303064	Study to Evaluate Weight Gain as Assessed by Change in BMI Z-score in Pediatric Subjects With Schizophrenia or Bipolar I Disorder	RECRUITING	PHASE3
NCT06605599	Study of Oral ABBV-932 to Assess Adverse Events and Change in Disease Activity in Adult Participants With Bipolar I or II Disorder	COMPLETED	PHASE2
NCT03257865	A Trial to Assess Brexpiprazole Versus Placebo for the Treatment of Acute Manic Episodes, Associated With Bipolar I Disorder	COMPLETED	PHASE3
NCT07172516	A Randomized Study of Azetukalner Versus Placebo in Depressive Episodes Associated With Bipolar I or II Disorder (Bipolar Depression)	RECRUITING	PHASE3
NCT04578756	Open-Label, Flexible-dose Study to Evaluate the Long-Term Safety and Tolerability of Cariprazine in the Treatment of Pediatric Participants With Schizophrenia, Bipolar I Disorder, or Autism Spectrum Disorder	COMPLETED	PHASE3
NCT03259555	A Trial to Assess Brexpiprazole Versus Placebo for the Treatment of Acute Manic Episodes Associated With Bipolar I Disorder	COMPLETED	PHASE3
NCT00107731	Efficacy & Safety of Seroquel Plus Mood Stabilizer in the Maintenance of Bipolar I Disorder	COMPLETED	PHASE3
NCT04777357	A Study to Assess Change in Disease Activity and Adverse Events (AEs) With Cariprazine in the Treatment of Depressive Episodes in Pediatric Participants Participants (10 to 17 Years of Age) With Bipolar I Disorder.	RECRUITING	PHASE3

Related Pages

All Bipolar i disorder trials All trials in Miami, United States